difference between tirzepatide and semaglutide for weight loss outperformed weight-loss drug results in real world patients, study shows Semaglutide vs Tirzepatide results

For patients and healthcare providers, the appeal is clear: retatrutide may finally address the full spectrum of metabolic dysfunctionfrom obesity and diabetes to fatty liver diseaseoffering a treatment option that is both broader in scope and more powerful in effect

In humans, neuroimaging studies show associative evidence that GLP-1 agonists alter brain responses to food cues, potentially dampening the neural reactivity to appetizing foods that may trigger binge episodes in susceptible individuals

The 12 mg dose produced 28.3% average body weight loss at 80 weeks, and a higher-BMI two-year subgroup reached 30.3% average loss at 104 weeks

(2019) Chaperone-mediated autophagy is involved in the execution of ferroptosis, Proc